Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae

Antimicrobial Agents and Chemotherapy
Sarit MarkovichNir Osherov

Abstract

The antifungal agent caspofungin (CAS) specifically interferes with glucan synthesis and cell wall formation. To further study the cellular processes affected by CAS, we analyzed a Saccharomyces cerevisiae mutant collection (4,787 individual knockout mutations) to identify new genes affecting susceptibility to the drug. This collection was screened for increased CAS sensitivity (CAS-IS) or increased CAS resistance (CAS-IR). MICs were determined by the broth microdilution method. Disruption of 20 genes led to CAS-IS (four- to eightfold reductions in the MIC). Eleven of the 20 genes are involved in cell wall and membrane function, notably in the protein kinase C (PKC) integrity pathway (MID2, FKS1, SMI1, and BCK1), chitin and mannan biosynthesis (CHS3, CHS4, CHS7, and MNN10), and ergosterol biosynthesis (ERG5 and ERG6). Four of the 20 genes (TPO1, VPS65, VPS25, and CHC1) are involved in vacuole and transport functions, 3 of the 20 genes (CCR4, POP2, and NPL3) are involved in the control of transcription, and 2 of the 20 genes are of unknown function. Disruption of nine additional genes led to CAS-IR (a fourfold increase of MIC). Five of these nine genes (SLG1, ERG3, VRP1, CSG2, and CKA2) are involved in cell wall function and sig...Continue Reading

References

Sep 1, 1990·Microbiological Reviews·D J KlionskyS D Emr
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·C M DouglasM el-Sherbeini
Nov 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·T F ChanX F Zheng
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·Sevtap ArikanJohn H Rex
Jan 5, 2002·Expert Opinion on Investigational Drugs·P G Goekjian, M R Jirousek
Jan 22, 2002·Medical Mycology·C M Douglas
May 23, 2002·The Journal of Biological Chemistry·Christine DesmoucellesBertrand Daignan-Fornier
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·Nir OsherovD P Kontoyiannis
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·William R KirkpatrickThomas F Patterson
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Alexandra S Blackburn, Simon V Avery
Feb 7, 2003·Current Drug Targets. Infectious Disorders·J Ruiz-Herrera, G San-Blas
Mar 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Amani ZewailJing Huang
Dec 4, 2003·Fungal Genetics and Biology : FG & B·Gretel M GuestMichelle Momany
Dec 4, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Dimitrios P Kontoyiannis, Russell E Lewis

❮ Previous
Next ❯

Citations

Jun 15, 2005·Nature Reviews. Microbiology·James B Anderson
Jul 4, 2012·Molecular BioSystems·Sheena D Singh-BabakLeah E Cowen
Feb 5, 2013·The Journal of Antimicrobial Chemotherapy·Ute ZeidlerChristophe d'Enfert
Sep 22, 2010·Antimicrobial Agents and Chemotherapy·Janet F StaabKieren A Marr
Jan 24, 2008·Antimicrobial Agents and Chemotherapy·Georgios ChamilosDimitrios P Kontoyiannis
Dec 19, 2007·Antimicrobial Agents and Chemotherapy·Jason M CotaNathan P Wiederhold
Jun 3, 2009·Antimicrobial Agents and Chemotherapy·Kristy DolanDamian J Krysan
Jul 9, 2008·Applied and Environmental Microbiology·Daniel Gonzalez-RamosRamon Gonzalez
Apr 1, 2008·Eukaryotic Cell·Leah E Cowen, William J Steinbach
Nov 16, 2010·Eukaryotic Cell·Joaquín AriñoAsier González
Jun 9, 2006·Microbiology and Molecular Biology Reviews : MMBR·Guillaume Lesage, Howard Bussey
Jun 8, 2011·Microbiology and Molecular Biology Reviews : MMBR·Rebecca S ShapiroLeah E Cowen
Apr 5, 2008·PLoS Pathogens·Louise A WalkerNeil A R Gow
May 1, 2010·Medical Mycology·Nadereh Mir-RashedMyron L Smith
Dec 25, 2010·Trends in Cell Biology·Juan S Bonifacino, Aitor Hierro
Dec 9, 2008·Trends in Microbiology·Isabel Sá-CorreiaNuno P Mira
Oct 1, 2005·Molecular Microbiology·Kimberly J GerikJennifer K Lodge
Aug 23, 2012·Molecular Microbiology·Kelley R HealeyThomas D Edlind
Jun 16, 2007·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·David S Perlin
Sep 8, 2006·International Journal of Antimicrobial Agents·Stephanie St George, Claude P Selitrennikoff
Aug 16, 2005·Fungal Genetics and Biology : FG & B·Brian D Shaw, Srijana Upadhyay
Sep 23, 2009·Fungal Genetics and Biology : FG & B·Louise A WalkerCarol A Munro
Dec 25, 2012·Nanoscale·Sofiane El-Kirat-ChatelYves F Dufrêne
Jun 7, 2014·Frontiers in Physiology·Catarina CostaMiguel C Teixeira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.